BPIFB4 and diabetic cardiomyopathy: These findings call for an in-depth investigation of the mitochondrial metabolic network to determine its contribution in the maintenance of cardiac health in long-living individuals and the possible therapeutic exploitation of LAV-BPIFB4 gene transfer for the treatment of diabetic cardiomyopathy.